Dimethylamine → HCID 57732854、化合物
反応式
FC(F)(F)[C:3](O)=[O:4].[CH2:8]([N:10]([CH3:40])[C:11]1[N:16]=[CH:15][C:14]([C:17]2[CH:18]=[C:19]3[C:23](=[C:24]([C:26]([NH2:28])=[O:27])[CH:25]=2)[NH:22][CH:21]=[C:20]3[CH:29]2[CH2:34][CH2:33][N:32]([S:35]([CH2:38][CH3:39])(=[O:37])=[O:36])[CH2:31][CH2:30]2)=[CH:13][CH:12]=1)[CH3:9].CNC>>[CH2:38]([S:35]([N:32]1[CH2:33][CH2:34][CH:29]([C:20]2[C:19]3[C:23](=[C:24]([C:26]([NH2:28])=[O:27])[CH:25]=[C:17]([C:14]4[CH:15]=[N:16][C:11]([N:10]5[CH2:40][CH2:3][O:4][CH2:9][CH2:8]5)=[CH:12][CH:13]=4)[CH:18]=3)[NH:22][CH:21]=2)[CH2:30][CH2:31]1)(=[O:37])=[O:36])[CH3:39]参加物
3
実験手順
The title compound was prepared according to the general procedure of 5-{6-[ethyl(methyl)amino]-3-pyridinyl}-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide trifluoroacetate, substituting morpholine (1 mL) for dimethylamine to afford 40.1 mg of the title compound (69.5%).
後処理
- customThe title compound was prepared
出典と根拠
- ORDレコード
- ord-4c2dfb297ba54d4c8c0c70d1e2a64e64
- 出典データセット
- uspto-grants-2013_01